UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Walker Asset Management LLC

Walker Asset Management LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 23.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 626 shares of the healthcare conglomerate’s stock after selling 192 shares during the quarter. Walker Asset Management LLC’s holdings in UnitedHealth Group were worth $317,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at $32,000. Quarry LP boosted its position in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $37,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $510.03 on Friday. The firm has a fifty day moving average of $551.50 and a 200-day moving average of $562.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $469.37 billion, a P/E ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.83 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, UBS Group cut their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $627.74.

View Our Latest Analysis on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.